A352940 Stock Overview
Enbio Co., Ltd. produces and sells pesticides in South Korea.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
ENBIO Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩2,995.00 |
52 Week High | ₩6,490.00 |
52 Week Low | ₩2,865.00 |
Beta | 1.02 |
1 Month Change | -6.26% |
3 Month Change | -14.55% |
1 Year Change | -28.00% |
3 Year Change | -71.61% |
5 Year Change | n/a |
Change since IPO | -75.45% |
Recent News & Updates
Recent updates
Shareholder Returns
A352940 | KR Chemicals | KR Market | |
---|---|---|---|
7D | 0% | 0.1% | 2.4% |
1Y | -28.0% | -18.5% | 12.2% |
Return vs Industry: A352940 underperformed the KR Chemicals industry which returned -18.5% over the past year.
Return vs Market: A352940 underperformed the KR Market which returned 12.2% over the past year.
Price Volatility
A352940 volatility | |
---|---|
A352940 Average Weekly Movement | 3.5% |
Chemicals Industry Average Movement | 4.7% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 11.9% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A352940 has not had significant price volatility in the past 3 months.
Volatility Over Time: A352940's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1997 | n/a | M.J. Lee | https://www.enbio.co.kr |
Enbio Co., Ltd. produces and sells pesticides in South Korea. It offers fungi-insecticides, fungicides, insecticides, herbicides, plant growth regulars, and fertilizers. The company was founded in 1997 and is headquartered in Gunpo, South Korea.
ENBIO Co., Ltd. Fundamentals Summary
A352940 fundamental statistics | |
---|---|
Market cap | ₩32.55b |
Earnings (TTM) | -₩6.30b |
Revenue (TTM) | ₩34.02b |
1.0x
P/S Ratio-5.2x
P/E RatioIs A352940 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A352940 income statement (TTM) | |
---|---|
Revenue | ₩34.02b |
Cost of Revenue | ₩26.97b |
Gross Profit | ₩7.05b |
Other Expenses | ₩13.35b |
Earnings | -₩6.30b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -579.73 |
Gross Margin | 20.73% |
Net Profit Margin | -18.52% |
Debt/Equity Ratio | 29.8% |
How did A352940 perform over the long term?
See historical performance and comparison